Is Tenax Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Tenax Therapeutics Inc (TENX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Tenax Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tenax Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Tenax Therapeutics Inc?

Muslim investors may consider investing in Tenax Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Tenax Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Tenax Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Tenax Therapeutics Inc updated?

The Shariah compliance status of Tenax Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Tenax Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Tenax Therapeutics Inc?

You can check the latest Shariah compliance status of Tenax Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

TENX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 12, 2026

Report Source: 2025 Annual Report

Tenax Therapeutics Inc. Stock Analysis TENX

United States Health Care Micro Cap Report: 2025 Annual

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company is headquartered in Chapel Hill, North Carolina and currently employs 14 full-time employees. The firm is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The firm's products include TNX-201 (oral enteric-coated imatinib) and TNX-103 (oral levosimendan). The firm is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The Company’s other programs include TNX-101 and TNX-102. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The firm has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).

Key Statistics of Tenax Therapeutics Inc (TENX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$11.40$12.37

Today's Open

$11.74

Volume

775.40K

P/E Ratio (TTM)

52 Week Range

$5.34$18.38

Market Cap

214.80M

Avg. Volume

672.05K

Dividend Yield

Financial Metrics & Statements of Tenax Therapeutics Inc (TENX)

FAQ's for Tenax Therapeutics Inc (TENX)

According to Musaffa’s Shariah screening methodology, Tenax Therapeutics Inc (TENX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.